Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem. The Pharmacovigilance Programme of India (PvPI) has progressed considerably in the last few years. The Pharmacovigilance Programme of India (PvPI) was approved by the Ministry of Health and Family Welfare (MOHFW), Government of India (GOI) in July 2010 with the primary objective of the programme to create a nation-wide system for patient safety reporting.
The National Medical Commission (NMC) requires every medical college in India to have a Pharmacovigilance Committee. Therefore, the Pharmacovigilance Committee of Sri Venkateswaraa Medical College Hospital and Research Institute has been constituted to oversee and ensure the effective monitoring of adverse drug reactions (ADRs) and medication safety within the institution.
1. Ensure Patient Safety: Identify, assess, and prevent adverse drug reactions to enhance overall patient care.
2. Promote ADR Reporting: Encourage and facilitate healthcare professionals and students to report adverse drug reactions (ADR).
3. Enhance Drug Safety Awareness: Conduct training sessions, workshops, and awareness programs on pharmacovigilance.
4. Strengthen Drug Monitoring Systems: Develop and maintain a robust database for the collection and analysis of ADRs.
5. Collaborate with Regulatory Bodies: Maintain compliance with the National Pharmacovigilance Programme of India (PvPI) and contribute to national drug safety initiatives.
6. Improve Prescription Practices: Provide evidence-based recommendations for safer drug prescribing patterns.
7. Encourage Research and Development: Support studies on drug safety, adverse reactions, and risk assessment.
1. To promote awareness regarding adverse drug reactions (ADRs) among healthcare professionals and students.
2. To facilitate the reporting, collection, and analysis of ADRs for patient safety.
3. To ensure compliance with the guidelines of the National Pharmacovigilance Programme of India (PvPI).
4. To conduct training sessions, workshops, and awareness programs related to drug safety and pharmacovigilance.
5. To establish a robust reporting mechanism within the hospital.
1. Encourage voluntary reporting of ADRs from healthcare providers.
2. Maintain a database for all reported ADRs and submit periodic reports to the regulatory authorities.
3. Collaborate with Regional ADR Monitoring Centre and Pharmacovigilance Programme of India (PvPI), Ghaziabad for knowledge sharing and research.
4. Recommend necessary changes in prescribing patterns and medication safety to enhance patient safety.
Sno | President / Secretary / Members | Name | Designation |
---|---|---|---|
1 | Chairman | Dr. Anand. D | Dean |
2 | Convener/Coordinator | Dr. Srinivasan.V | Professor, Pharmacology |
3 | Deputy Coordinator | Dr. Samuthiravel. S | Associate Professor, General Medicine |
4 | Member | Dr. Sujith Kumar. S | Professor, General Surgery |
5 | Member | Dr. Jayalakshmi. V | Associate Professor, Anaesthesiology |
6 | Member | Dr. Akshaya. N | Senior Resident, Dermatology |
7 | Member | Dr. Muvulla Ganesh Kumar | Assistant Professor, Radiodiagnosis |
8 | Member | Dr. Violet Kezia Amirtha | Senior Resident, Obstetrics & Gynecology |
9 | Member | Ms. Deva kirubai Mozhi C | Medication Safety Nurse |
10 | Member | Ms. Gajalakshmi K.T. | Nursing Superintendent |
11 | Member | Mr. Ilamurugu. P | Incharge - Central Pharmacy |